The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an incompletely reversible limitation in airflow. A physiological variable--the forced expiratory volume in one second (FEV1)--is often used to grade the severity of COPD. However, patients with COPD have systemic manifestations that are not reflected by the FEV1. We hypothesized that a multidimensional grading system that assessed the respiratory and systemic expressions of COPD would better categorize and predict outcome in these patients. METHODS: We first evaluated 207 patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test. We used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death. We then prospectively validated the index in a cohort of 625 patients, with death from any cause and from respiratory causes as the outcome variables. RESULTS: There were 25 deaths among the first 207 patients and 162 deaths (26 percent) in the validation cohort. Sixty-one percent of the deaths in the validation cohort were due to respiratory insufficiency, 14 percent to myocardial infarction, 12 percent to lung cancer, and 13 percent to other causes. Patients with higher BODE scores were at higher risk for death; the hazard ratio for death from any cause per one-point increase in the BODE score was 1.34 (95 percent confidence interval, 1.26 to 1.42; P<0.001), and the hazard ratio for death from respiratory causes was 1.62 (95 percent confidence interval, 1.48 to 1.77; P<0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger than that for the FEV1 (0.74 vs. 0.65). CONCLUSIONS: The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The BODE index [BMI, airflow limitation (forced expiratory volume in one second), dyspnea and 6-min walk distance], which has been externally validated in at least 13 additional cohorts following the original derivation. The BODE index has been cited as the prognostic model of choice by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and it formed the basis for listing recommendations in the 2014 ISHLT candidate selection guidelines. (4, 166–168)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [166]
In the citing paper
“Although COPD remains the most common indication for lung transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
In the citing paper
“the BODE score (body mass index, degree of airway obstruction, dyspnea, and exercise capacity score) is still the most important indicator, and along with it, FEV1 and the presence or absence of acute exacerbation determine whether transplantation is possible based on the presence or absence of evidence for pulmonary arterial hypertension (PAH), as summarized in Table 2 [3,42].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Research works printed but not linked: 1
- Burrows B, 1991, Eur Respir Rev, 1, 340
Cited by
Items 101–200 of 1,007
Gosker, H. R., Zeegers, M. P., Wouters, E. F. M., & Schols, A. M. W. J. (2007) · Thorax · doi:10.1136/thx.2007.078980 · Cited by 303
“36 For fibre type II these relations are inverse, by the definition of fibre type proportions.”
Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease: Incidence and Predicting Factors
de Torres, J. P., Marín, J. M., Casanova, C., Cote, C., Carrizo, S., Cordoba-Lanus, E., Baz-Dávila, R., Zulueta, J. J., Aguirre-Jaime, A., Saetta, M., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0430oc · Cited by 304
Self-citationDreher, M., Storre, J. H., Schmoor, C., & Windisch, W. (2010) · Thorax · doi:10.1136/thx.2009.124263 · Cited by 308
Systemic Effects of Chronic Obstructive Pulmonary Disease
Agustí, A. G. N. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-026sr · Cited by 292
“Thus, weight loss identifies a new systemic domain of COPD not considered by the traditional measures of lung function (39).”
BackgroundMethodHan, M. K., Agusti, A., Celli, B. R., Criner, G. J., Halpin, D. M. G., Roche, N., Papi, A., Stockley, R. A., Wedzicha, J., & Vogelmeier, C. F. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3328pp · Cited by 276
“Likewise, FEV1 is one of the most powerful predictors of clinically relevant outcomes, including symptoms, exacerbations, and mortality (6, 7).”
BackgroundSelf-citationMcAllister, D. A., Maclay, J. D., Mills, N. L., Mair, G., Miller, J., Anderson, D., Newby, D. E., Murchison, J. T., & MacNee, W. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1080oc · Cited by 292
“However, low BMI is a marker of more severe COPD (30) and is likely to reflect a more catabolic state, which may explain this apparently contradictory finding, as well as explain why other metabolic factors such as hyperglycemia and hypercholesterolemia were not significantly associated with PWV in our cohort.”
BackgroundResultC-reactive protein levels and clinically important predictive outcomes in stable COPD patients
de Torres, J. P., Cordoba-Lanus, E., López-Aguilar, C., Muros de Fuentes, M., Montejo de Garcini, A., Aguirre-Jaime, A., Celli, B. R., & Casanova, C. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00109605 · Cited by 297
“Patients were clinically stable (no exacerbation for 2 months) at the time of evaluation and were a sub-sample of those studied in the BODE (body mass index, obstruction, dyspnoea and exercise capacity) international multicentre study [ 13 ].”
MethodSelf-citationThe natural history of chronic obstructive pulmonary disease
Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024605 · Cited by 265
Factors affecting survival of hospitalised patients with COPD
Gunen, H., Hacievliyagil, S. S., Kosar, F., Mutlu, L. C., Gulbas, G., Pehlivan, E., Sahin, I., & Kizkin, O. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00024804 · Cited by 288
“Confirming the findings of SORIANO et al. [20], almost identical mortality rates for outpatients with COPD were reported very recently by CELLI et al. [ 21 ].”
BackgroundResultBenzo, R., Wigle, D., Novotny, P., Wetzstein, M., Nichols, F., Shen, R. K., Cassivi, S., & Deschamps, C. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.011 · Cited by 283
Level of daily physical activity in individuals with COPD compared with healthy controls
Vorrink, S. N., Kort, H. S., Troosters, T., & Lammers, J.-W. J. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-33 · Cited by 272
“It does not correlate well with important outcomes such as symptoms, quality of life, survival, exacerbation frequency, and exercise tolerance [29-31].”
BackgroundLindenauer, P. K., Stefan, M. S., Pekow, P. S., Mazor, K. M., Priya, A., Spitzer, K. A., Lagu, T. C., Pack, Q. R., Pinto-Plata, V. M., & ZuWallack, R. (2020) · JAMA · doi:10.1001/jama.2020.4437 · Cited by 272
Self-citationAgusti, À., & Soriano, J. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550801941349 · Cited by 276
“The so-called BODE index (a composite score that includes Body weight (as reflected by the body mass index), the degree of airflow Obstruction (as indicated by the FEV1 value, expressed as percentage of the reference value), the degree of Dyspnoea perceived by the patient (as quantified by the MMRC questionnaire) and…”
Palliative and end-of-life care for patients with severe COPD
Curtis, J. R. (2008) · European Respiratory Journal · doi:10.1183/09031936.00126107 · Cited by 275
Validation of predictive rules and indices of severity for community acquired pneumonia
Ewig, S. (2004) · Thorax · doi:10.1136/thx.2003.008110 · Cited by 290
Disease Staging and Prognosis in Smokers Using Deep Learning in Chest Computed Tomography
González, G., Ash, S. Y., Vegas-Sánchez-Ferrero, G., Onieva Onieva, J., Rahaghi, F. N., Ross, J. C., Díaz, A., San José Estépar, R., & Washko, G. R. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0860oc · Cited by 281
“In addition, in the ECLIPSE cohort and in the subgroup of participants with COPD in the COPDGene cohort, the performance of the CNN was also compared with the performance of the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index, a multicomponent predictor of mortality (36).”
MethodInfluence of anxiety on health outcomes in COPD
Eisner, M. D., Blanc, P. D., Yelin, E. H., Katz, P. P., Sanchez, G., Iribarren, C., & Omachi, T. A. (2010) · Thorax · doi:10.1136/thx.2009.126201 · Cited by 284
“We also used the validated BODE index, which is a multimodal measure of disease severity.(21) The BODE index is based on the body mass index (B), the degree of airflow obstruction (O) measured by forced expiratory volume in 1 s (FEV1), grade of dyspnoea (D) assessed by the modified Medical Research Council (MRC) dyspn…”
BackgroundMethodPredictors of Rehospitalization and Death After a Severe Exacerbation of COPD
McGhan, R., Radcliff, T., Fish, R., Sutherland, E. R., Welsh, C., & Make, B. (2007) · Chest · doi:10.1378/chest.06-3018 · Cited by 282
Socioeconomic status, race and COPD health outcomes
Eisner, M. D., Blanc, P. D., Omachi, T. A., Yelin, E. H., Sidney, S., Katz, P. P., Ackerson, L. M., Sanchez, G., Tolstykh, I., & Iribarren, C. (2011) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2009.089722 · Cited by 266
“We also used the validated BODE index, which is a multimodal measure of disease severity.(30) The BODE index is based on the body mass index (B), the degree of airflow obstruction (O) measured by forced expiratory volume in 1 s (FEV1), grade of dyspnoea (D) assessed by the modified Medical Research Council (MRC) Dyspn…”
MethodDefining the Asthma-COPD Overlap Syndrome in a COPD Cohort
Cosio, B. G., Soriano, J. B., López-Campos, J. L., Calle-Rubio, M., Soler-Cataluna, J. J., de-Torres, J. P., Marín, J. M., Martínez-Gonzalez, C., de Lucas, P., Mir, I., et al. (2016) · Chest · doi:10.1378/chest.15-1055 · Cited by 270
“The percentage of FEV1, BMI, 6MWD, and mMRC values were integrated into the BODE index as previously described.(13) Emphysema was defined by a radiologist diagnosis on CT scan or DLCO < 80% without other alternative explanation.”
MethodSelf-citationGarcia-Rio, F., Lores, V., Mediano, O., Rojo, B., Hernanz, A., López-Collazo, E., & Alvarez-Sala, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1873oc · Cited by 275
COPD and multimorbidity: Recognising and addressing a syndemic occurrence
Fabbri, L. M., Celli, B. R., Agustí, A., Criner, G. J., Dransfield, M. T., Divo, M., Krishnan, J. K., Lahousse, L., Montes de Oca, M., Salvi, S. S., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00261-8 · Cited by 274
Self-citationDahl, R., Chung, K. F., Buhl, R., Magnussen, H., Nonikov, V., Jack, D., Bleasdale, P., Owen, R., Higgins, M., Kramer, B., et al. (2010) · Thorax · doi:10.1136/thx.2009.125435 · Cited by 273
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation
Crisafulli, E., Costi, S., Luppi, F., Cirelli, G., Cilione, C., Coletti, O., Fabbri, L. M., & Clini, E. M. (2008) · Thorax · doi:10.1136/thx.2007.086371 · Cited by 272
Mortality in COPD: Causes, Risk Factors, and Prevention
Berry, C. E., & Wise, R. A. (2010) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.510160 · Cited by 257
“Of the 162 deaths that occurred in this cohort over a median follow-up of 28 months, 61% were attributed to respiratory insufficiency, with the remaining deaths due to myocardial infarction (14%), lung cancer (12%), and miscellaneous causes (13%) (20).”
BackgroundMethodInfluentialStable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Leigh, R., Pizzichini, M. M. M., Morris, M. M., Maltais, F., Hargreave, F. E., & Pizzichini, E. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00072105 · Cited by 272
Factors Associated With Bronchiectasis in Patients With COPD
Martínez-García, M. Á., Soler-Cataluña, J. J., Donat Sanz, Y., Catalán Serra, P., Agramunt Lerma, M., Ballestín Vicente, J., & Perpiñá-Tordera, M. (2011) · Chest · doi:10.1378/chest.10-1758 · Cited by 267
CT Scan Findings of Emphysema Predict Mortality in COPD
Haruna, A., Muro, S., Nakano, Y., Ohara, T., Hoshino, Y., Ogawa, E., Hirai, T., Niimi, A., Nishimura, K., Chin, K., et al. (2010) · Chest · doi:10.1378/chest.09-2836 · Cited by 267
Systemic inflammation in chronic obstructive pulmonary disease: a population-based study
EPI-SCAN Steering Committee, Garcia-Rio, F., Miravitlles, M., Soriano, J. B., Muñoz, L., Duran-Tauleria, E., Sánchez, G., Sobradillo, V., & Ancochea, J. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-63 · Cited by 264
“COPD severity was determined by the GOLD criteria and the BODE index [9,17].”
MethodRecognising and managing key transitions in end of life care
Boyd, K., & Murray, S. A. (2010) · BMJ · doi:10.1136/bmj.c4863 · Cited by 260
“Disease specific prognostic tools use statistical models to predict the risks of individuals dying from conditions such as heart failure, chronic obstructive pulmonary disease, or liver disease. These tools tend to be used in clinical trials or when selecting patients for treatments like transplantation, but less ofte…”
BackgroundThe Relationship Between COPD and Frailty
Marengoni, A., Vetrano, D. L., Manes-Gravina, E., Bernabei, R., Onder, G., & Palmer, K. (2018) · Chest · doi:10.1016/j.chest.2018.02.014 · Cited by 256
Pulmonary hypertension in COPD: results from the ASPIRE registry
Hurdman, J., Condliffe, R., Elliot, C. A., Swift, A., Rajaram, S., Davies, C., Hill, C., Hamilton, N., Armstrong, I. J., Billings, C., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00079512 · Cited by 262
Jones, R. C., Donaldson, G. C., Chavannes, N. H., Kida, K., Dickson-Spillmann, M., Harding, S., Wedzicha, J. A., Price, D., & Hyland, M. E. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0271oc · Cited by 262
“One highly regarded composite measure is the BODE [body mass index (B), degree of airflow obstruction (O), dyspnea (D), and exercise capacity (E)] Index (7), which was originally designed to predict mortality in COPD.”
BackgroundHaemoglobin level and its clinical impact in a cohort of patients with COPD
Cote, C., Zilberberg, M. D., Mody, S. H., Dordelly, L. J., & Celli, B. (2007) · European Respiratory Journal · doi:10.1183/09031936.00137106 · Cited by 258
“Study subjects The present study was a retrospective analysis of data prospectively collected at one of the sites (Bay Pines Veterans Affairs Medical Centre, Bay Pines, FL, USA) of the multicentre BODE study cohort [ 8 ].”
BackgroundMethodSelf-citationGuía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Riesco, J. A., Trigueros, J. A., Piñera, P., Simón, A., et al. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2012.04.001 · Cited by 257
From Current Opinion in Pulmonary Medicine
Blanchette, C. M., Berry, S. R., & Lane, S. J. (2011) · Cited by 261
Estépar, R. S. J., Kinney, G. L., Black-Shinn, J. L., Bowler, R. P., Kindlmann, G. L., Ross, J. C., Kikinis, R., Han, M. K., Come, C. E., Diaz, A. A., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0162oc · Cited by 255
“Using the spirometric measures of lung function, Modified Medical Research Council dyspnea score (30), body mass index, and 6-MWD, the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) multidimensional index to predict mortality in COPD was calculated (31).”
MethodTsai, L. L. Y., McNamara, R. J., Moddel, C., Alison, J. A., McKenzie, D. K., & McKeough, Z. J. (2017) · Respirology · doi:10.1111/resp.12966 · Cited by 247
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study
Han, M. K., Muellerova, H., Curran-Everett, D., Dransfield, M. T., Washko, G. R., Regan, E. A., Bowler, R. P., Beaty, T. H., Hokanson, J. E., Lynch, D. A., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70044-9 · Cited by 250
Gender and COPD in Patients Attending a Pulmonary Clinic
de Torres, J. P., Casanova, C., Hernández, C., Abreu, J., Aguirre-Jaime, A., & Celli, B. R. (2005) · Chest · doi:10.1378/chest.128.4.2012 · Cited by 255
Self-citationPuhan, M. A., Scharplatz, M., Troosters, T., & Steurer, J. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-54 · Cited by 249
“Hence patients with frequent exacerbations have more pronounced skeletal muscle weakness and a more limited six minute walking distance [15], which is in turn a risk factor for exacerbations and mortality [3,16].”
BackgroundBody Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis
Cao, C., Wang, R., Wang, J., Bunjhoo, H., Xu, Y., & Xiong, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043892 · Cited by 247
“Although the hallmark feature of COPD is airflow obstruction, it was poorly predicted by Forced Expiratory Volume in the first second (FEV1) only [3,4].”
BackgroundA Multidimensional Grading System (BODE Index) as Predictor of Hospitalization for COPD
Ong, K.-C., Earnest, A., & Lu, S.-J. (2005) · Chest · doi:10.1378/chest.128.6.3810 · Cited by 251
Impact of COPD Exacerbations on Patient-Centered Outcomes
Cote, C. G., Dordelly, L. J., & Celli, B. R. (2007) · Chest · doi:10.1378/chest.06-1610 · Cited by 250
Self-citationPrognostic Value of the Objective Measurement of Daily Physical Activity in Patients With COPD
Garcia-Rio, F., Rojo, B., Casitas, R., Lores, V., Madero, R., Romero, D., Galera, R., & Villasante, C. (2012) · Chest · doi:10.1378/chest.11-2014 · Cited by 241
Systemic Manifestations of COPD
Nussbaumer-Ochsner, Y., & Rabe, K. F. (2011) · Chest · doi:10.1378/chest.10-1252 · Cited by 246
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
Nishiyama, O., Taniguchi, H., Kondoh, Y., Kimura, T., Kato, K., Kataoka, K., Ogawa, T., Watanabe, F., & Arizono, S. (2010) · European Respiratory Journal · doi:10.1183/09031936.00152609 · Cited by 246
Outcomes and markers in the assessment of chronic obstructive pulmonary disease
Jones, P. W., & Agusti, A. G. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00145104 · Cited by 244
Foreman, M. G., Zhang, L., Murphy, J., Hansel, N. N., Make, B., Hokanson, J. E., Washko, G., Regan, E. A., Crapo, J. D., Silverman, E. K., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1928oc · Cited by 238
“The BODE (body mass index, airflow obstruction, dyspnea, and exercise capacity) Index score was calculated for each subject (19).”
MethodMakita, H., Nasuhara, Y., Nagai, K., Ito, Y., Hasegawa, M., Betsuyaku, T., Onodera, Y., Hizawa, N., Nishimura, M., & the Hokkaido COPD Cohort Study Group (2007) · Thorax · doi:10.1136/thx.2006.072777 · Cited by 246
Reproducibility of 6-minute walking test in patients with COPD
Hernandes, N. A., Wouters, E. F. M., Meijer, K., Annegarn, J., Pitta, F., & Spruit, M. A. (2011) · European Respiratory Journal · doi:10.1183/09031936.00142010 · Cited by 233
Sciurba, F. C., Criner, G. J., Strange, C., Shah, P. L., Michaud, G., Connolly, T. A., Deslée, G., Tillis, W. P., Delage, A., Marquette, C.-H., et al. (2016) · JAMA · doi:10.1001/jama.2016.6261 · Cited by 242
Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease
Diaz, A. A., Orejas, J. L., Grumley, S., Nath, H. P., Wang, W., Dolliver, W. R., Yen, A., Kligerman, S. J., Jacobs, K., Manapragada, P. P., et al. (2023) · JAMA · doi:10.1001/jama.2023.2065 · Cited by 217
Sevenoaks, M. J., & Stockley, R. A. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-70 · Cited by 241
“Low body mass index (BMI), age, and low arterial oxygen tension have been shown to be significant independent predictors of mortality in COPD [27,28].”
BackgroundPrognostic Value of the Hematocrit in Patients With Severe COPD Receiving Long-term Oxygen Therapy
Chambellan, A., Chailleux, E., & Similowski, T. (2005) · Chest · doi:10.1378/chest.128.3.1201 · Cited by 241
The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD
Cote, C. G., Pinto-Plata, V., Kasprzyk, K., Dordelly, L. J., & Celli, B. R. (2007) · Chest · doi:10.1378/chest.07-2050 · Cited by 240
Self-citationMaddocks, M., Lovell, N., Booth, S., Man, W. D.-C., & Higginson, I. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32127-x · Cited by 222
Chu, C. M. (2004) · Thorax · doi:10.1136/thx.2004.024307 · Cited by 236
Roshanravan, B., Gamboa, J., & Wilund, K. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.01.051 · Cited by 225
Jones, L. W., Eves, N. D., Haykowsky, M., Joy, A. A., & Douglas, P. S. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70195-5 · Cited by 226
Ioanna, T., Kocks, J., Tzanakis, N., Siafakas, N., & van der Molen, T. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00029 · Cited by 231
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach
Hoogendoorn, M., Hoogenveen, R. T., Rutten-van Mölken, M. P., Vestbo, J., & Feenstra, T. L. (2011) · European Respiratory Journal · doi:10.1183/09031936.00043710 · Cited by 228
Severity-Related Changes of Bronchial Microbiome in Chronic Obstructive Pulmonary Disease
Garcia-Nuñez, M., Millares, L., Pomares, X., Ferrari, R., Pérez-Brocal, V., Gallego, M., Espasa, M., Moya, A., & Monsó, E. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01967-14 · Cited by 229
“ity, as assessed by the 6-min walking test) (14).”
BackgroundMethodCelli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0044st · Cited by 220
Self-citationPedometers to enhance physical activity in COPD: a randomised controlled trial
Mendoza, L., Horta, P., Espinoza, J., Aguilera, M., Balmaceda, N., Castro, A., Ruiz, M., Díaz, O., & Hopkinson, N. S. (2015) · European Respiratory Journal · doi:10.1183/09031936.00084514 · Cited by 223
Casanova, C., de Torres, J. P., Aguirre-Jaíme, A., Pinto-Plata, V., Marin, J. M., Cordoba, E., Baz, R., Cote, C., & Celli, B. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0831oc · Cited by 224
Self-citationPuri, R., Iung, B., Cohen, D. J., & Rodés-Cabau, J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv756 · Cited by 216
CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study
Lynch, D. A., Moore, C. M., Wilson, C., Nevrekar, D., Jennermann, T., Humphries, S. M., Austin, J. H. M., Grenier, P. A., Kauczor, H.-U., Han, M. K., et al. (2018) · Radiology · doi:10.1148/radiol.2018172294 · Cited by 217
“2 118 (11) 95 (17) 153 (26) 173 (36) 86 (25) 30 (21)”
MethodQuantitative Assessment of Emphysema, Air Trapping, and Airway Thickening on Computed Tomography
KOLD Study Group, Lee, Y. K., Oh, Y.-M., Lee, J.-H., Kim, E. K., Lee, J. H., Kim, N., Seo, J. B., & Lee, S. D. (2008) · Lung · doi:10.1007/s00408-008-9071-0 · Cited by 220
“In addition, the BODE index (Body mass index, airflow Obstruction, Dyspnea, and Exercise capacity), an integrative prognostic factor of COPD, was calculated [32].”
MethodSymptom-Based Questionnaire for Identifying COPD in Smokers
Price, D. B., Tinkelman, D. G., Halbert, R. J., Nordyke, R. J., Isonaka, S., Nonikov, D., Juniper, E. F., Freeman, D., Hausen, T., Levy, M. L., et al. (2006) · Respiration · doi:10.1159/000090142 · Cited by 217
“make accurate diagnosis increasingly important. These results quantify the contribution of individual patient-reported items in identifying COPD. The strongest discriminators were increasing age, pack-years of smoking, decreasing BMI, phlegm in the absence of a cold, and a cough affected by the weather. Morning phlegm…”
BackgroundDetection of Rheumatoid Arthritis–Interstitial Lung Disease Is Enhanced by Serum Biomarkers
Doyle, T. J., Patel, A. S., Hatabu, H., Nishino, M., Wu, G., Osorio, J. C., Golzarri, M. F., Traslosheros, A., Chu, S. G., Frits, M. L., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-1950oc · Cited by 215
Simple functional performance tests and mortality in COPD
Puhan, M. A., Siebeling, L., Zoller, M., Muggensturm, P., & ter Riet, G. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131612 · Cited by 208
Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort
Spruit, M. A., Watkins, M. L., Edwards, L. D., Vestbo, J., Calverley, P. M. A., Pinto-Plata, V., Celli, B. R., Tal-Singer, R., & Wouters, E. F. M. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.12.007 · Cited by 210
Self-citationSarcopenia correlates with systemic inflammation in COPD
Byun, M. K., Cho, E. N., Chang, J., Ahn, C. M., & Kim, H. J. (2017) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s130790 · Cited by 204
“The BODE index ranges from 0 to 10 points, with higher scores indicating a greater risk of death in COPD.”
InfluentialComplications of lung resection and exercise capacity: A meta-analysis
Benzo, R., Kelley, G. A., Recchi, L., Hofman, A., & Sciurba, F. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.02.012 · Cited by 211
Soler, X., Gaio, E., Powell, F. L., Ramsdell, J. W., Loredo, J. S., Malhotra, A., & Ries, A. L. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201407-336oc · Cited by 211
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
Kornmann, O., Dahl, R., Centanni, S., Dogra, A., Owen, R., Lassen, C., & Kramer, B. (2011) · European Respiratory Journal · doi:10.1183/09031936.00045810 · Cited by 213
Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women
Varraso, R., Fung, T. T., Barr, R. G., Hu, F. B., Willett, W., & Camargo, C. A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.488 · Cited by 210
“Among patients with COPD, leanness is a major risk factor for poor prognosis (11, 12).”
BackgroundQuality-of-Life Determinants in Patients With Clinically Stable Bronchiectasis
Martínez-García, M. A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J. J. (2005) · Chest · doi:10.1378/chest.128.2.739 · Cited by 208
Vogelmeier, C., Buhl, R., Criée, C., Gillissen, A., Kardos, P., Köhler, D., Magnussen, H., Morr, H., Nowak, D., Pfeiffer-Kascha, D., et al. (2007) · Pneumologie · doi:10.1055/s-2007-959200 · Cited by 202
Divo, M. J., Casanova, C., Marin, J. M., Pinto-Plata, V. M., de-Torres, J. P., Zulueta, J. J., Cabrera, C., Zagaceta, J., Sanchez-Salcedo, P., Berto, J., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00171614 · Cited by 195
Self-citationObesity and respiratory diseases
Murugan, A., & Sharma, G. (2008) · Chronic Respiratory Disease · doi:10.1177/1479972308096978 · Cited by 201
Validation and comparison of reference equations for the 6-min walk distance test
Cote, C. G., Casanova, C., Marín, J. M., Lopez, M. V., Pinto-Plata, V., de Oca, M. M., Dordelly, L. J., Nekach, H., & Celli, B. R. (2008) · European Respiratory Journal · doi:10.1183/09031936.00104507 · Cited by 204
“The present study confirms the threshold of clinical relevance for the 6MWD, as described in the original BODE study [ 19 ].”
BackgroundResultSelf-citationRaju, S. V., Jackson, P. L., Courville, C. A., McNicholas, C. M., Sloane, P. A., Sabbatini, G., Tidwell, S., Tang, L. P., Liu, B., Fortenberry, J. A., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0733oc · Cited by 199
“Furthermore, low BMI has been associated with increased mortality in COPD (33) and implicates the role of CFTR deficiency in reducing gastrointestinal tract function in smokers.”
BackgroundWilliams, M. C., Murchison, J. T., Edwards, L. D., Agustí, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., Lomas, D. A., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2012-203151 · Cited by 205
Self-citationCelli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00009015 · Cited by 204
Self-citationProfiling serum biomarkers in patients with COPD: associations with clinical parameters
Pinto-Plata, V., Toso, J., Lee, K., Park, D., Bilello, J., Mullerova, H., De Souza, M. M., Vessey, R., & Celli, B. (2007) · Thorax · doi:10.1136/thx.2006.064428 · Cited by 205
Self-citationRutten-van Mölken, M. P. M. H., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006) · Chest · doi:10.1378/chest.130.4.1117 · Cited by 198
Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis
Ekberg-Aronsson, M., Pehrsson, K., Nilsson, J.-Å., Nilsson, P. M., & Löfdahl, C.-G. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-98 · Cited by 200
“To assess prognosis in patients with established COPD, the BODE-index for prediction of mortality (based on degree of airflow limitation, dyspnea, 6 min walking distance and body mass index) has been developed [5].”
MethodCharacteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Agusti, A., Edwards, L. D., Celli, B., MacNee, W., Calverley, P. M. A., Müllerova, H., Lomas, D. A., Wouters, E., Bakke, P., Rennard, S., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00195212 · Cited by 201
“The BODE index was calculated according to Celli et al [12].”
MethodSelf-citationBellou, V., Belbasis, L., Konstantinidis, A. K., Tzoulaki, I., & Evangelou, E. (2019) · BMJ · doi:10.1136/bmj.l5358 · Cited by 197
COPD and cognitive impairment: the role of hypoxemia and oxygen therapy
Eisner (2010) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s10684 · Cited by 184
“28–30”
Steuten, L. M. G., Creutzberg, E. C., Vrijhoef, H. J. M., & Wouters, E. F. (2006) · Primary Care Respiratory Journal · doi:10.1016/j.pcrj.2005.09.001 · Cited by 184
“The BODE-study, however, was performed in a secondary care setting with a group of elderly patients, most of them suffering from severe COPD [ 7 ].”
BackgroundMethodInfluentialCelli, B., Vestbo, J., Jenkins, C. R., Jones, P. W., Ferguson, G. T., Calverley, P. M. A., Yates, J. C., Anderson, J. A., Willits, L. R., & Wise, R. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0665oc · Cited by 186
Self-citationPredictors of mortality in COPD
Celli, B. R. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.12.017 · Cited by 187
Self-citationA review of national guidelines for management of COPD in Europe
Miravitlles, M., Vogelmeier, C., Roche, N., Halpin, D., Cardoso, J., Chuchalin, A. G., Kankaanranta, H., Sandström, T., Śliwiński, P., Zatloukal, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01170-2015 · Cited by 188
Cellular Markers of Muscle Atrophy in Chronic Obstructive Pulmonary Disease
Plant, P. J., Brooks, D., Faughnan, M., Bayley, T., Bain, J., Singer, L., Correa, J., Pearce, D., Binnie, M., & Batt, J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0382oc · Cited by 190
Celli, B. R., Halbert, R. J., Nordyke, R. J., & Schau, B. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.041 · Cited by 185
Self-citationBody Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
Alakhras, M., Decker, P. A., Nadrous, H. F., Collazo-Clavell, M., & Ryu, J. H. (2007) · Chest · doi:10.1378/chest.06-2784 · Cited by 186
Role for Interleukin-6 in COPD-Related Pulmonary Hypertension
Chaouat, A., Savale, L., Chouaid, C., Tu, L., Sztrymf, B., Canuet, M., Maitre, B., Housset, B., Brandt, C., Le Corvoisier, P., et al. (2009) · Chest · doi:10.1378/chest.08-2420 · Cited by 180
Metadata
- Authors
- Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J.
- Affiliations
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Clínico Universitario de Caracas (VE)
- Boston University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-04
- Volume
- 350
- Issue
- 10
- Pages
- 1005-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139347600
- Semantic Scholar
- 12606ed46f2e1cd6f56b679b445a8fda29690f65
- Cited by
- 4,015
- References
- 36
- Citations by year
- 2026: 88 · 2025: 115 · 2024: 153 · 2023: 132 · 2022: 124 · 2021: 176 · 2020: 199 · 2019: 158 · 2018: 192 · 2017: 184 · 2016: 206 · 2015: 185 · 2014: 241 · 2013: 230 · 2012: 242
- FWCI
- 135.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- chronic obstructive pulmonary disease, BODE index, body mass index, airflow obstruction, dyspnea, exercise capacity, 6-minute walk test, mortality prediction, FEV1, disease severity classification, respiratory mortality
- MeSH terms
- Aged, Airway Obstruction, Dyspnea, Forced Expiratory Volume, Humans, Middle Aged, Prospective Studies, Risk, Risk Factors, Severity of Illness Index, Body Mass Index, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.